134 related articles for article (PubMed ID: 31090199)
1. KMT2A histone methyltransferase contributes to colorectal cancer development by promoting cathepsin Z transcriptional activation.
Fang Y; Zhang D; Hu T; Zhao H; Zhao X; Lou Z; He Y; Qin W; Xia J; Zhang X; Ye LC
Cancer Med; 2019 Jul; 8(7):3544-3552. PubMed ID: 31090199
[TBL] [Abstract][Full Text] [Related]
2. KMT2A regulates cervical cancer cell growth through targeting VDAC1.
Zhang C; Hua Y; Qiu H; Liu T; Long Q; Liao W; Qiu J; Wang N; Chen M; Shi D; Yan Y; Xie C; Deng W; Li T; Li Y
Aging (Albany NY); 2020 May; 12(10):9604-9620. PubMed ID: 32436862
[TBL] [Abstract][Full Text] [Related]
3. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.
Zhang C; Song C; Liu T; Tang R; Chen M; Gao F; Xiao B; Qin G; Shi F; Li W; Li Y; Fu X; Shi D; Xiao X; Kang L; Huang W; Wu X; Tang B; Deng W
Cell Death Dis; 2017 Jul; 8(7):e2940. PubMed ID: 28726783
[TBL] [Abstract][Full Text] [Related]
4. KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.
Li J; Yu B; Deng P; Cheng Y; Yu Y; Kevork K; Ramadoss S; Ding X; Li X; Wang CY
Nat Commun; 2017 Apr; 8():15146. PubMed ID: 28440295
[TBL] [Abstract][Full Text] [Related]
5. RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.
Matthijssens F; Sharma ND; Nysus M; Nickl CK; Kang H; Perez DR; Lintermans B; Van Loocke W; Roels J; Peirs S; Demoen L; Pieters T; Reunes L; Lammens T; De Moerloose B; Van Nieuwerburgh F; Deforce DL; Cheung LC; Kotecha RS; Risseeuw MD; Van Calenbergh S; Takarada T; Yoneda Y; van Delft FW; Lock RB; Merkley SD; Chigaev A; Sklar LA; Mullighan CG; Loh ML; Winter SS; Hunger SP; Goossens S; Castillo EF; Ornatowski W; Van Vlierberghe P; Matlawska-Wasowska K
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33555272
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia.
Wu Z; Eguchi-Ishimae M; Yagi C; Iwabuki H; Gao W; Tauchi H; Inukai T; Sugita K; Ishii E; Eguchi M
Br J Haematol; 2015 Dec; 171(5):818-29. PubMed ID: 26403224
[TBL] [Abstract][Full Text] [Related]
7. MLL/KMT2A translocations in diffuse large B-cell lymphomas.
Gindin T; Murty V; Alobeid B; Bhagat G
Hematol Oncol; 2015 Dec; 33(4):239-46. PubMed ID: 25131304
[TBL] [Abstract][Full Text] [Related]
8. PCGF1 promotes epigenetic activation of stemness markers and colorectal cancer stem cell enrichment.
Ji G; Zhou W; Du J; Zhou J; Wu D; Zhao M; Yang L; Hao A
Cell Death Dis; 2021 Jun; 12(7):633. PubMed ID: 34148069
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin.
Svoboda LK; Bailey N; Van Noord RA; Krook MA; Harris A; Cramer C; Jasman B; Patel RM; Thomas D; Borkin D; Cierpicki T; Grembecka J; Lawlor ER
Oncotarget; 2017 Jan; 8(1):458-471. PubMed ID: 27888797
[TBL] [Abstract][Full Text] [Related]
10. Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway.
Li W; Yu X; Ma X; Xie L; Xia Z; Liu L; Yu X; Wang J; Zhou H; Zhou X; Yang Y; Liu H
Cell Signal; 2018 Oct; 50():131-141. PubMed ID: 30018008
[TBL] [Abstract][Full Text] [Related]
11. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
12. ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.
Zhu L; Li Q; Wong SH; Huang M; Klein BJ; Shen J; Ikenouye L; Onishi M; Schneidawind D; Buechele C; Hansen L; Duque-Afonso J; Zhu F; Martin GM; Gozani O; Majeti R; Kutateladze TG; Cleary ML
Cancer Discov; 2016 Jul; 6(7):770-83. PubMed ID: 27154821
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a DOT1L inhibitor-sensitive human acute monocytic leukemia cell line YBT-5 with a novel KMT2A-MLLT3 fusion.
Wang Z; Shi Y; Liu H; Liang Z; Zhu Q; Wang L; Tang B; Miao S; Ma N; Cen X; Ren H; Dong Y
Hematol Oncol; 2019 Dec; 37(5):617-625. PubMed ID: 31701557
[TBL] [Abstract][Full Text] [Related]
14. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH
Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596
[TBL] [Abstract][Full Text] [Related]
15. Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.
Lin W; Francis JM; Li H; Gao X; Pedamallu CS; Ernst P; Meyerson M
Cancer Biol Ther; 2016 Dec; 17(12):1274-1281. PubMed ID: 27801610
[TBL] [Abstract][Full Text] [Related]
16. Neuronal Deletion of Kmt2a/Mll1 Histone Methyltransferase in Ventral Striatum is Associated with Defective Spike-Timing-Dependent Striatal Synaptic Plasticity, Altered Response to Dopaminergic Drugs, and Increased Anxiety.
Shen EY; Jiang Y; Javidfar B; Kassim B; Loh YE; Ma Q; Mitchell AC; Pothula V; Stewart AF; Ernst P; Yao WD; Martin G; Shen L; Jakovcevski M; Akbarian S
Neuropsychopharmacology; 2016 Dec; 41(13):3103-3113. PubMed ID: 27485686
[TBL] [Abstract][Full Text] [Related]
17. Neuronal Kmt2a/Mll1 histone methyltransferase is essential for prefrontal synaptic plasticity and working memory.
Jakovcevski M; Ruan H; Shen EY; Dincer A; Javidfar B; Ma Q; Peter CJ; Cheung I; Mitchell AC; Jiang Y; Lin CL; Pothula V; Stewart AF; Ernst P; Yao WD; Akbarian S
J Neurosci; 2015 Apr; 35(13):5097-108. PubMed ID: 25834037
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice.
Sevenich L; Schurigt U; Sachse K; Gajda M; Werner F; Müller S; Vasiljeva O; Schwinde A; Klemm N; Deussing J; Peters C; Reinheckel T
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2497-502. PubMed ID: 20133781
[TBL] [Abstract][Full Text] [Related]
19. The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.
Serio J; Ropa J; Chen W; Mysliwski M; Saha N; Chen L; Wang J; Miao H; Cierpicki T; Grembecka J; Muntean AG
Oncogene; 2018 Jan; 37(4):450-460. PubMed ID: 28945229
[TBL] [Abstract][Full Text] [Related]
20. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
